Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort
Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to joint damage. While screening questionnaires have been developed, their performance varies. The objective of this study was to develop a referral tool for dermatologists to identify psoriasis patients with conco...
Saved in:
Main Authors: | Tamara W. van Hal (Author), Michelle L.M. Mulder (Author), Mark H. Wenink (Author), Frank H.J. van den Hoogen (Author), Jake S.F. Maurits (Author), Marcel C. Pasch (Author), Juul M.P.A. van den Reek (Author), Elke M.G.J. de Jong (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort
by: Tamara W. van Hal, et al.
Published: (2022) -
The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
by: van Muijen ME, et al.
Published: (2020) -
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
by: Linda Davidson, et al.
Published: (2022) -
Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
by: Selma Atalay, et al.
Published: (2021) -
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study
by: Marisol E. Otero, et al.
Published: (2019)